{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:55:07Z","timestamp":1777722907772,"version":"3.51.4"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Background: Studies show that hyperuricemia is an element of the pathophysiology of many conditions. Therefore, the aim of this study was to assess primary care physicians\u2019 knowledge and attitudes toward asymptomatic hyperuricemia and gout management. Methods: A survey-based cross-sectional study was conducted to assess the primary physicians\u2019 attitudes, knowledge, and patient management regarding hyperuricemia and gout. Results: A total of 336 primary care physicians were included. Physicians who read at least one scientific paper covering the topic of hyperuricemia in the past year scored significantly higher in knowledge questions (N = 152, 6.5 \u00b1 2.05 vs. N = 183, 7.04 \u00b1 2.14, p = 0.019). Only around half of physicians correctly identified drugs that can lower or elevate serum uric acid levels. Furthermore, the analysis of correct answers to specific questions showed poor understanding of the pathophysiology of hyperuricemia and possible risk factors. Conclusions: This study identified gaps in primary care physicians\u2019 knowledge essential for the adequate management of patients with asymptomatic hyperuricemia and gout. As hyperuricemia and gout are among the fastest rising non-communicable diseases, greater awareness of the available guidelines and more education about the causes and risks of hyperuricemia among primary care physicians may reduce the development of diseases that have hyperuricemia as risk factors.<\/jats:p>","DOI":"10.3390\/ijerph18031234","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T06:22:20Z","timestamp":1611987740000},"page":"1234","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["How Are We Managing Patients with Hyperuricemia and Gout: A Cross Sectional Study Assessing Knowledge and Attitudes of Primary Care Physicians?"],"prefix":"10.3390","volume":"18","author":[{"given":"Sanja","family":"Zuzic Furlan","sequence":"first","affiliation":[{"name":"Department of Family Medicine, University of Split School of Medicine, 21000 Split, Croatia"},{"name":"Department of Family Medicine, Split-Dalmatia County Health Center, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Rusic","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-0635","authenticated-orcid":false,"given":"Josko","family":"Bozic","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Rumboldt","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6811-275X","authenticated-orcid":false,"given":"Zvonko","family":"Rumboldt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Split School of Medicine, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Rada","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Split School of Medicine, 21000 Split, Croatia"},{"name":"Department of Family Medicine, Split-Dalmatia County Health Center, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2148-3227","authenticated-orcid":false,"given":"Marion","family":"Tomicic","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Split School of Medicine, 21000 Split, Croatia"},{"name":"Department of Family Medicine, Split-Dalmatia County Health Center, 21000 Split, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,30]]},"reference":[{"key":"ref_1","first-page":"3167","article-title":"Update on the epidemiology, genetics, and therapeutic options of hyperuricemia","volume":"12","author":"Li","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Halperin Kuhns, V.L., and Woodward, O.M. (2020). Sex Differences in Urate Handling. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124269"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14397595.2020.1784556","article-title":"Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data","volume":"31","author":"Koto","year":"2021","journal-title":"Mod. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Koto, R., Nakajima, A., Horiuchi, H., and Yamanaka, H. (2020). Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data. Pharmacoepidemiol. Drug Saf.","DOI":"10.1002\/pds.5127"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7861\/clinmedicine.17-1-54","article-title":"Gout\u2014A guide for the general and acute physicians","volume":"17","author":"Abhishek","year":"2017","journal-title":"Clin. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Winder, M., Owczarek, A.J., Mossakowska, M., Broczek, K., Grodzicki, T., Wierucki, \u0141., and Chudek, J. (2021). Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles-Results from a Population-Based PolSenior Study. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18020387"},{"key":"ref_7","first-page":"2153","article-title":"Can genetics aggravate the health of isolated and remote populations? The case of gout, hyperuricaemia and osteoarthritis in Dalmatia","volume":"13","author":"Budimir","year":"2013","journal-title":"Rural Remote Health"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Vu\u010dak, J., Kati\u0107, M., Bielen, I., Vrdoljak, D., Lali\u0107, D.I., Kranj\u010devi\u0107, K., and Markovi\u0107, B.B. (2012). Association between hyperuricemia, prediabetes, and prehypertension in the Croatian adult population\u2014A cross-sectional study. BMC Cardiovasc. Disord., 12.","DOI":"10.1186\/1471-2261-12-117"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/clc.23433","article-title":"Clinical relevance of serum uric acid and abdominal aortic-calcification in a national survey","volume":"43","author":"Li","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_10","first-page":"1","article-title":"Changes in the Leading Cause of Death: Recent Patterns in Heart Disease and Cancer Mortality","volume":"254","author":"Heron","year":"2016","journal-title":"NCHS Data Brief"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","article-title":"Epidemiology of cardiovascular disease in China: Current features and implications","volume":"16","author":"Zhao","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","article-title":"Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review","volume":"21","author":"Einarson","year":"2018","journal-title":"Value Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/hrt.2005.072173","article-title":"Cost of cardiovascular diseases in the United Kingdom","volume":"92","author":"Leal","year":"2006","journal-title":"Heart"},{"key":"ref_14","first-page":"39","article-title":"Analysis of the Economic Impact of Cardiovascular Diseases in the Last Five Years in Brazil","volume":"109","author":"Siqueira","year":"2017","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_15","unstructured":"(2020, March 20). Sample Size Calculator. Available online: https:\/\/www.surveymonkey.com\/mp\/sample-size-calculator\/."},{"key":"ref_16","unstructured":"Hrvatski Zavod za Zdravstveno Osiguranje (2020, March 20). Ugovoreni Sadr\u017eaji Zdravstvene Za\u0161tite u RH, Available online: https:\/\/www.hzzo.hr\/zdravstveni-sustav-rh\/zdravstvena-zastita-pokrivena-obveznim-zdravstvenim-osiguranjem\/ugovoreni-sadrzaji-zdravstvene-zastite-u-rh\/."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.15537\/smj.2018.12.23715","article-title":"Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia","volume":"39","author":"Alqarni","year":"2018","journal-title":"Saudi Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5603\/CJ.a2019.0034","article-title":"Study of epidemiological aspects of hyperuricemia in Poland","volume":"26","author":"Widecka","year":"2019","journal-title":"Cardiol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.semarthrit.2020.04.007","article-title":"The biology of urate","volume":"50","author":"Keenan","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_20","first-page":"CD008652","article-title":"Pharmacotherapy for hyperuricaemia in hypertensive patients. The Cochrane database of systematic reviews","volume":"9","author":"Gois","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/cclm-2015-0523","article-title":"Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: A systematic review and meta-analysis","volume":"54","author":"Braga","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kumric, M., Borovac, J.A., Kurir, T.T., and Bozic, J. (2021). Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review. Life, 11.","DOI":"10.3390\/life11010053"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjcard.2011.09.042","article-title":"Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention","volume":"109","author":"Kaya","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mandurino-Mirizzi, A., Cornara, S., Somaschini, A., Demarchi, A., Galazzi, M., Puccio, S., Montalto, C., Crimi, G., Ferlini, M., and Camporotondo, R. (2020). Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Nutr. Metab. Cardiovasc. Dis.","DOI":"10.1016\/j.numecd.2020.10.020"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2459\/JCM.0000000000000926","article-title":"Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction","volume":"21","author":"Demarchi","year":"2020","journal-title":"J. Cardiovasc. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.11622\/smedj.2016129","article-title":"Poorly controlled gout: Who is doing poorly?","volume":"57","author":"Chia","year":"2016","journal-title":"Singap. Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10787-020-00694-7","article-title":"Better outcomes for patients with gout","volume":"28","author":"Day","year":"2020","journal-title":"Inflammopharmacology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/RHU.0b013e3181896c35","article-title":"Gout: What primary care physicians want to know","volume":"14","author":"Dore","year":"2008","journal-title":"J. Clin. Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5114\/reum.2020.100140","article-title":"Pathophysiology of hyperuricemia and its clinical significance\u2014A narrative review","volume":"58","author":"Skoczynska","year":"2020","journal-title":"Reumatologia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.semarthrit.2020.04.010","article-title":"Therapeutic approaches in the treatment of gout","volume":"50","author":"Pillinger","year":"2020","journal-title":"Semin. Arthritis Rheum."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/3\/1234\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:17:26Z","timestamp":1760159846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/3\/1234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijerph18031234"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18031234","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}